308 related articles for article (PubMed ID: 6873013)
21. Hepatotoxicity of agents that enhance formation of focal hepatocellular proliferative lesions (putative preneoplastic foci) in a rapid rat liver bioassay.
Ward JM; Tsuda H; Tatematsu M; Hagiwara A; Ito N
Fundam Appl Toxicol; 1989 Jan; 12(1):163-71. PubMed ID: 2925015
[TBL] [Abstract][Full Text] [Related]
22. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver.
Grasl-Kraupp B; Bursch W; Ruttkay-Nedecky B; Wagner A; Lauer B; Schulte-Hermann R
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9995-9. PubMed ID: 7937932
[TBL] [Abstract][Full Text] [Related]
23. Tumor promotion in rat liver.
Herren SL; Pereira MA
Environ Health Perspect; 1983 Apr; 50():123-9. PubMed ID: 6135606
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study.
Columbano A; Ledda-Columbano GM; Rao PM; Rajalakshmi S; Sarma DS
Am J Pathol; 1984 Sep; 116(3):441-6. PubMed ID: 6476080
[TBL] [Abstract][Full Text] [Related]
25. Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
Schulte-Hermann R; Kraupp-Grasl B; Bursch W; Gerbracht U; Timmermann-Trosiener I
Toxicol Pathol; 1989; 17(4 Pt 1):642-9; discussion 649-50. PubMed ID: 2576472
[TBL] [Abstract][Full Text] [Related]
26. Effect of tumor promoters on proliferation of putative preneoplastic cells in rat liver.
Schulte-Hermann R; Schuppler J; Ohde G; Timmermann-Trosiener I
Carcinog Compr Surv; 1982; 7():99-105. PubMed ID: 6175416
[No Abstract] [Full Text] [Related]
27. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Carcinogenesis; 1996 May; 17(5):947-54. PubMed ID: 8640942
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic properties of preneoplastic rat liver lesions and applications to detection of carcinogens and tumor promoters.
Williams GM
Toxicol Pathol; 1998; 26(3):452-3. PubMed ID: 9608653
[No Abstract] [Full Text] [Related]
29. Stimulation of DNA synthesis in rat and mouse liver by various tumor promoters.
Büsser MT; Lutz WK
Carcinogenesis; 1987 Oct; 8(10):1433-7. PubMed ID: 2443263
[TBL] [Abstract][Full Text] [Related]
30. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
31. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
[TBL] [Abstract][Full Text] [Related]
32. Selective dieldrin promotion of hepatic focal lesions in mice.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Carcinogenesis; 1996 Jun; 17(6):1243-50. PubMed ID: 8681438
[TBL] [Abstract][Full Text] [Related]
33. Proliferation of rat liver cells in preneoplastic nodules after stimulation of liver growth by xenobiotic inducers.
Ohde G; Schuppler J; Schulte-Hermann R; Keiger H
Arch Toxicol Suppl; 1979; (2):451-5. PubMed ID: 88929
[No Abstract] [Full Text] [Related]
34. Oral contraceptive steroids as promoters or complete carcinogens for liver in female Sprague-Dawley rats.
Yager JD
Environ Health Perspect; 1983 Apr; 50():109-12. PubMed ID: 6135605
[TBL] [Abstract][Full Text] [Related]
35. Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation.
Gerlyng P; Grotmol T; Seglen PO
Carcinogenesis; 1994 Feb; 15(2):371-9. PubMed ID: 7508825
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis.
Garcea R; Daino L; Pascale R; Simile MM; Puddu M; Frassetto S; Cozzolino P; Seddaiu MA; Gaspa L; Feo F
Cancer Res; 1989 Apr; 49(7):1850-6. PubMed ID: 2564313
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy and autophagic protein degradation as determinants of hepatocellular growth and survival.
Seglen PO
Cell Biol Toxicol; 1997 Jul; 13(4-5):301-15. PubMed ID: 9298250
[TBL] [Abstract][Full Text] [Related]
38. Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication.
Chaumontet C; Suschetet M; Honikman-Leban E; Krutovskikh VA; Berges R; Le Bon AM; Heberden C; Shahin MM; Yamasaki H; Martel P
Nutr Cancer; 1996; 26(3):251-63. PubMed ID: 8910908
[TBL] [Abstract][Full Text] [Related]
39. Preneoplastic and neoplastic progression during hepatocarcinogenesis in mice injected with diethylnitrosamine in infancy.
Goldfarb S; Pugh TD; Koen H; He YZ
Environ Health Perspect; 1983 Apr; 50():149-61. PubMed ID: 6873010
[TBL] [Abstract][Full Text] [Related]
40. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures.
Columbano A; Rajalakshmi S; Sarma DS
Cancer Res; 1981 Jun; 41(6):2079-83. PubMed ID: 6113048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
